Once-promising anti-inflammatory drug fails to improve long-COVID functional outcomes in trial
Frerieke / Flickr cc A randomized clinical trial finds that the anti-inflammatory drug colchicine, once thought promising for treating COVID-19, ...
Tag: longCOVID
Studies show mostly poor long-COVID protection for Paxlovid
Two new studies find limited evidence of the usefulness of Paxlovid (nirmatrelvir-ritonavir) to prevent the development of long COVID—but with ...
Long-COVID symptoms in young kids can vary by age
Babies and toddlers 2 years and under experienced different long-COVID symptoms than preschoolers ages 3 to 5 years, according to ...
Study shows for most, long-COVID symptoms persist into second year
A new study based on German long-COVID patients shows 68% experience the same symptoms in year 2 as in year ...
Long-COVID study shows high rates of cognitive change
Two new studies add to the growing body of literature on the lasting effects of long COVID. In the first, ...
Studies show long-COVID symptoms distinct from other respiratory infections, common in Marines
Two new studies offer fresh insights into long COVID, with the first noting a greater neurological, cognitive, and fatigue impact ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!